Ketamine for PTSD Treatment
Ketamine has emerged as a promising therapy for patients suffering from PTSD, providing rapid and substantial relief. If you, or someone you know, continue to struggle with the complex symptoms of PTSD, please call Summit Ketamine Innovations and set up a free consultation to discover how ketamine infusions may be able to provide the relief you’ve been longing for.
PTSD is typically treated with a combination of cognitive-behavioral therapy (CBT), a type of psychotherapy designed to change harmful thinking and behavior patterns, and serotonin reuptake inhibitor (SSRI) medication.
Unfortunately, SSRIs, which increase your brain’s serotonin levels to reduce depression and PTSD symptoms, take approximately 4-6 weeks to work. Ketamine infusion therapy, meanwhile, can begin to take effect in as little as a single 50-minute treatment.
What is PTSD?
PTSD is a psychiatric disorder that can develop after you experience or witness a traumatic event. While most people associate PTSD with military personnel and veterans, it can also happen to sexual assault victims, accident survivors, childhood abuse victims, and even those who have witnessed one of these experiences.
Those suffering from PTSD often feel sad, angry, lost, or detached from the people they love.
How Does Ketamine Help PTSD?
Medical experts believe that ketamine works by binding to the NMDA receptors in the brain, increasing the amount of the neurotransmitter glutamate. This neurotransmitter then activates your AMPA receptors, which affect mood, cognition, and thought patterns.
While some PTSD patients have experienced dramatic improvements, results vary, so you and your provider will work together to design the right ketamine infusion therapy plan for you.
If your PTSD symptoms haven’t responded to traditional treatments, call our expert team of Ketamine Infusion of Parker to learn more about Ketamine Infusion Therapy for PTSD.
Additional Resources & Scientific Articles
Feder, Parides et al. “Efficacy of intravenous ketamine for treatment of chronic posttraumatic stress disorder: a randomized clinical trial.” JAMA Psychiatry. 2014 Jun;71(6):681-8.
SUMMARY: In this double blind, placebo-controlled cross over study, a single dose of Ketamine (.5mg/kg over 40 minutes) was compared to midazolam. Authors note a significant immediate reduction in the CAPS score and frequently this reduction was maintained for over 2 weeks. The only side effects noted were transient dissociative symptoms, none of which required stopping the infusion.